Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona

被引：0

作者：

Xavier Solanich

Raúl Rigo-Bonnin

Victor-David Gumucio

Paul Bastard

Jérémie Rosain

Quentin Philippot

Xosé-Luis Perez-Fernandez

Maria-Paz Fuset-Cabanes

Miguel-Ángel Gordillo-Benitez

Guillermo Suarez-Cuartin

Enric Boza-Hernandez

Antoni Riera-Mestre

Alba Parra-Martínez

Roger Colobran

Arnau Antolí

Sergio Navarro

Gemma Rocamora-Blanch

Mario Framil

Laura Calatayud

Xavier Corbella

Jean-Laurent Casanova

Francisco Morandeira

Joan Sabater-Riera

机构：

[1] Hospital Universitari de Bellvitge,Department of Internal Medicine

[2] L’Hospitalet de Llobregat,Department of Clinical Laboratory

[3] Bellvitge Biomedical Research Institute (IDIBELL),Department of Intensive Care

[4] L’Hospitalet de Llobregat,Laboratory of Human Genetics of Infectious Diseases, Necker Branch

[5] Hospital Universitari de Bellvitge,Imagine Institute

[6] L’Hospitalet de Llobregat,St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch

[7] Hospital Universitari de Bellvitge,Department of Respiratory Medicine

[8] L’Hospitalet de Llobregat,Department of Anesthesiology

[9] INSERM U1163,Faculty of Medicine and Health Sciences

[10] Necker Hospital for Sick Children,Infection in Immunocompromised Pediatric Patients Research Group

[11] University of Paris,Pediatric Infectious Diseases and Immunodeficiencies Unit

[12] The Rockefeller University,Immunology Division, Genetics Department

[13] Hospital Universitari de Bellvitge,Diagnostic Immunology Research Group

[14] L’Hospitalet de Llobregat,Immunology Unit. Department of Cellular Biology, Physiology and Immunology

[15] Hospital Universitari de Bellvitge,Department of Immunology

[16] L’Hospitalet de Llobregat,Department of Microbiology

[17] Universitat de Barcelona,School of Medicine

[18] Vall d’Hebron Institut de Recerca (VHIR),undefined

[19] Vall d’Hebron Barcelona Hospital Campus,undefined

[20] Hospital Universitari Vall d’Hebron,undefined

[21] Vall d’Hebron Barcelona Hospital Campus,undefined

[22] Hospital Universitari Vall d’Hebron,undefined

[23] Vall d’Hebron Barcelona Hospital Campus,undefined

[24] Vall d’Hebron Institut de Recerca (VHIR),undefined

[25] Vall d’ Hebron Barcelona Hospital Campus,undefined

[26] Universitat Autònoma de Barcelona (UAB),undefined

[27] Hospital Universitari de Bellvitge,undefined

[28] L’Hospitalet de Llobregat,undefined

[29] Hospital Universitari de Bellvitge,undefined

[30] L’Hospitalet de Llobregat,undefined

[31] Universitat Internacional de Catalunya,undefined

[32] Howard Hughes Medical Institute,undefined

来源：

Journal of Clinical Immunology | 2021年 / 41卷

关键词：

COVID-19; SARS-CoV-2; acute kidney injury; type I interferons; auto-antibodies;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1733 / 1744

页数：11

共 50 条

[41] Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19
Nguyen, Chi
Crowe, Christopher L.
Kuti, Effie
Donato, Bonnie
Djaraher, Rachel
Seman, Leo
Graeter, Nancy
Power, Thomas P.
Mehra, Rinku
Willey, Vincent J.
JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2024, 11 (01): : 112 - 120
[42] Assessment of risk scores to predict mortality of COVID-19 patients admitted to the intensive care unit (vol 10, 1130218, 2023)
Nogueira, Matheus Carvalho Alves
Nobre, Vandack
Pires, Magda Carvalho
Ramos, Lucas Emanuel Ferreira
Ribeiro, Yara Cristina Neves Marques Barbosa
Aguiar, Rubia Laura Oliveira
Vigil, Flavia Maria Borges
Gomes, Virginia Mara Reis
Santos, Camila de Oliveira
Miranda, Davi Mesquita
Duraes, Pamela Andrea Alves
da Costa, Josiane Moreira
Schwarzbold, Alexandre Vargas
Gomes, Angelica Gomides dos Reis
Pessoa, Bruno Porto
Matos, Carolina Cunha
Cimini, Christiane Correa Rodrigues
Carvalho, Cintia Alcantara de
Ponce, Daniela
Manenti, Euler Roberto Fernandes
Cenci, Evelin Paola de Almeida
Anschau, Fernando
Costa, Flavia Carvalho Cardoso
Nascimento, Francine Janaina Magalhaes
Bartolazzi, Frederico
Grizende, Genna Maira Santos
Vianna, Heloisa Reniers
Nepomuceno, Jomar Cristeli
Ruschel, Karen Brasil
Zandona, Liege Barella
Castro, Luis Cesar de
Souza, Maira Dias
Carneiro, Marcelo
Bicalho, Maria Aparecida Camargos
Vilaca, Mariana do Nascimento
Bonardi, Naiara Patricia Fagundes
Oliveira, Neimy Ramos de
Lutkmeier, Raquel
Francisco, Saionara Cristina
Araujo, Silvia Ferreira
Delfino-Pereira, Polianna
Marcolino, Milena Soriano
FRONTIERS IN MEDICINE, 2024, 11
[43] Prevalence of Pre-existing Conditions Among Community Health Center Patients With COVID-19: Implications for the Patient Protection and Affordable Care Act
Huguet, Nathalie
Schmidt, Teresa
Larson, Annie
O'Malley, Jean
Hoopes, Megan
Angier, Heather
Marino, Miguel
DeVoe, Jennifer
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2021, 34 : S247 - S249
[44] Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients
Framil, Mario
Garcia-Serrano, Lydia
Morandeira, Francisco
Luchoro, Juan Francisco
Antoli, Arnau
Gomez-Vazquez, Jose Luis
Sierra-Fortuny, Angels
Solanich, Xavier
FRONTIERS IN IMMUNOLOGY, 2025, 16
[45] High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19
Scordio, Mirko
Frasca, Federica
Santinelli, Letizia
Sorrentino, Leonardo
Pierangeli, Alessandra
Turriziani, Ombretta
Mastroianni, Claudio M.
Antonelli, Guido
Viscidi, Raphael P.
d'Ettorre, Gabriella
Scagnolari, Carolina
CLINICAL IMMUNOLOGY, 2022, 241
[46] Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α
Mathian, Alexis
Breillat, Paul
Dorgham, Karim
Bastard, Paul
Charre, Caroline
Lhote, Raphael
Quentric, Paul
Moyon, Quentin
Mariaggi, Alice-Andree
Mouries-Martin, Suzanne
Mellot, Clara
Anna, Francois
Haroche, Julien
Cohen-Aubart, Fleur
Sterlin, Delphine
Zahr, Noel
Gervais, Adrian
Le Voyer, Tom
Bizien, Lucy
Amiot, Quentin
Pha, Micheline
Hie, Miguel
Chasset, Francois
Yssel, Hans
Miyara, Makoto
Charneau, Pierre
Ghillani-Dalbin, Pascale
Casanova, Jean-Laurent
Rozenberg, Flore
Amoura, Zahir
Gorochov, Guy
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12) : 1695 - 1703
[47] High in-hospital and post-discharge mortality in patients with a pre-existing diagnosis of heart failure hospitalized due to COVID-19
Niedziela, Jacek T.
Jaroszewicz, Jerzy
Wita, Krystian
Ciesla, Daniel
Gasior, Mariusz
KARDIOLOGIA POLSKA, 2022, 80 (01) : 90 - 92
[48] Peripheral neuropathy in COVID-19 is due to immune-mechanisms, pre-existing risk factors, anti-viral drugs, or bedding in the Intensive Care Unit
Finsterer, Josef
Scorza, Fulvio Alexandre
Scorza, Carla Alessandra
Fiorini, Ana Claudia
ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (10) : 924 - 928
[49] Association of glycosylated hemoglobin and outcomes in patients with COVID-19 and pre-existing type 2 diabetes A protocol for systematic review and meta-analysis
Zhang, Nie
Yun, Ruiyuan
Liu, Lin
Yang, Liu
MEDICINE, 2020, 99 (47) : E23392
[50] Immune determinants of cardiometabolic risk in pre-existing type-2 diabetes (T2D) severe COVID-19 patients
Gunasena, Manuja Gayashan Bandara
Wijewantha, Yasasvi
Bowman, Emily
Kumar, Amendra
Weragalaarachchi, Krishanthi
Furay, Jerra
Skladany, Tatum
Liu, Shan-lu
Vilgelm, Anna
Bednash, Joseph
Kasturiratna, Dhanuja
Demberg, Thorsten
Funderburg, Nicholas
Liyanage, Namal
JOURNAL OF IMMUNOLOGY, 2022, 208 (01):

← 1 2 3 4 5 →